Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
Clinical trial NCT01273155 · COMPLETED
Trial details
- NCT number
- NCT01273155
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-10
- Primary completion
- 2017-10-25
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.